These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 6689394)
1. [Acute hemodynamic effects of molsidomine in man]. Tartulier M; Ferrini M; Boutarin J; Ritz B Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):517-21. PubMed ID: 6689394 [TBL] [Abstract][Full Text] [Related]
2. [Substituted sydnonimines: hemodynamic effects and distribution of coronary blood flow in normal and ischemic myocardium]. Mosca SM; Gelpi RJ; Cingolani HE Acta Physiol Pharmacol Latinoam; 1985; 35(3):361-73. PubMed ID: 2938418 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease. Tsujibayashi T; Niwa A; Taniguchi K; Takeuchi J Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):163-7. PubMed ID: 3865742 [TBL] [Abstract][Full Text] [Related]
4. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment]. Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693 [TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic effects of sublingual molsidomine in patients with or without cardiac failure]. Rigaud M; Luwaert R; Jouret G; Bardet J; Bourdarias JP Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):523-8. PubMed ID: 6421222 [TBL] [Abstract][Full Text] [Related]
6. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)]. Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579 [No Abstract] [Full Text] [Related]
7. Analysis of oral molsidomine effects on ventricular function and dimensions in the conscious dog. Fiedler VB; Göbel H; Nitz RE Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):56-75. PubMed ID: 6409016 [TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic effects of molsidomine in chronic congestive heart failure]. Humar F; Maras P; Musitelli G; Camerini F G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413 [TBL] [Abstract][Full Text] [Related]
9. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine]. Berdeaux A; Giudicelli JF Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947 [TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic and coronary effects of molsidomine in patients with stable coronary insufficiency in the basal state, during an atrial stimulation test and a cold test]. Gourgon R; Neukirch F; Zygelman M; Michel PL; Mérillon JP; Pansard Y; Squara P; Laurent S; Dahan M; Juliard JM Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):529-34. PubMed ID: 6689395 [TBL] [Abstract][Full Text] [Related]
11. [Effect of nitroglycerin and N-ethoxycarbonyl-3-morpholinosydnonomine on the walls of large arteries]. Babalis D; Levy B; Azancot I; Georgiopoulos G; Beaufils P; Slama R Arch Mal Coeur Vaiss; 1982 Jun; 75(6):677-86. PubMed ID: 6810797 [TBL] [Abstract][Full Text] [Related]
12. Effects of molsidomine on the coronary circulation in anesthetized dogs. Fiedler VB; Nitz RE Basic Res Cardiol; 1982; 77(3):270-7. PubMed ID: 6896818 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and coronary effects of molsidomine at basal state, during atrial pacing, and during cold pressor test in patients with stable angina pectoris. Juliard JM; Neukirch F; Zygelman M; Merillon JP; Michel PL; Pansard Y; Dahan M; Gourgon R Am Heart J; 1985 Mar; 109(3 Pt 2):662-6. PubMed ID: 3838404 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of molsidomine by cardiac equilibrium blood pool scintigraphy. Chevigné M; Rigo P; Kassab A; Kulbertus H Am Heart J; 1985 Mar; 109(3 Pt 2):658-61. PubMed ID: 3838403 [TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)]. Fleck E; Dirschinger J; Rudolph W Herz; 1979 Jun; 4(3):285-92. PubMed ID: 457027 [No Abstract] [Full Text] [Related]
16. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease. Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction. Cantelli I; Lolli C; Brunelli A; Bracchetti D Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacological basis of therapy with molsidomine]. Bassenge E Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544 [TBL] [Abstract][Full Text] [Related]
19. [Influence of aspirin on the hemodynamic effects of molsidomine in healthy volunteers]. Weber S; de Lauture D; Puechavy C; Pipeau C; Chazelle F; Degeorges M Therapie; 1986; 41(3):153-7. PubMed ID: 3529482 [No Abstract] [Full Text] [Related]
20. Hemodynamic and myocardial effects of long-lasting venodilation in the conscious dog: analysis of molsidomine in comparison with nitrates. Holtz J; Bassenge E; Kolin A Basic Res Cardiol; 1978; 73(5):469-81. PubMed ID: 103534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]